Journal of Southern Medical University ›› 2014, Vol. 34 ›› Issue (05): 664-.
Previous Articles Next Articles
Online:
Published:
Abstract: Objective To establish a model bearing human lung cancer xenograft with bone metastasis in mice with normalimmune function. Methods Forty female C57BL/6J mice were randomly allocated into 4 equal groups, including a controlgroup and 3 immunosuppression groups treated with low, moderate, and high doses of dexamethasone (50, 100, and 150 mg,respectively). Four days after immune suppression, the mice were subjected to percutaneous injection of1.0×109 L-1 A549 cellsinto the tibial plateau, and the bone defects were assessed radiographically 28 days after modeling. HE staining andimmunohistochemical staining were used to examine the tumor tissues and bone tissue damages. Results In each of the 4groups one mouse died during tumor cell injection. Only 1 mouse showed tumor formation in low-dose immunosuppressiongroup, as compared to 7 and 4 in moderate- and high-dose immunosuppression groups. X-ray and microCT scan showedsignificant tibial bone destruction in moderate- and high-dose groups. The moderate- and high-dose groups showed similarALP activities but both were significantly higher than those in the other two groups (P<0.05). Conclusion Immunosuppressionwith a moderate dose of dexamethasone results in longer survival time of the human lung cancer xenograft-bearing modelmice as well as a higher tumor formation rate.
0 / / Recommend
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.j-smu.com/EN/
https://www.j-smu.com/EN/Y2014/V34/I05/664